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S  Seminal  studies  K  Key studies  R  Reviews  G  Guidance  MORE  Search for more studies
S  Vis ion counts  in US methadone maintenance cl inics  (1991). US cl inics  oriented to rehabi l i tation and long-term maintenance and which del ivered more
counsel l ing had the best outcomes. Results  later partia l ly confi rmed in a  repl ication study of a  larger set of US cl inics .
S  Abstinence-oriented ethos  undermines  methadone services  (1995). Austral ian study of two cl inics  a l located patients  purely on the bas is  of their home address ,
one oriented to abstinence, the other to indefini te maintenance. At the former this  ethos  led to lower doses  and time-l imited treatment, which were
counterproductive in terms of retention and substance use.
S  Ethos  and organisation in methadone services  (Austral ian Government, 1995). Comparison of three Austral ian cl inics  highl ights  the importance of good
organisation and an ethos  of individual ised treatment and care for patients , rather than acting as  a  more or less  efficient ‘methadone dispenary’.
K  Waiting time for methadone prescribing (National  Treatment Agency for Substance Misuse, 2004). Bri tish studies  show rapid entry enables  more referrals  to
engage with treatment and cuts  time at risk from i l legal  heroin use.
K  Methadone programme loosens  up, increases  capacity, patients  do just as  wel l  (2004). Canadian study documents  what happens when you ‘deregulate’
methadone prescribing and permit greater patient choice in treatment and treatment goals . Result: room for more patients , less  confl ict and no decrease in
effectiveness .
K  Bri tish GPs  as  effective as  specia l is t methadone cl inics  (2003). A two-year fol low-up of opiate dependent patients  sampled by the national  Engl ish NTORS study
showed that experienced or supported GPs can provide methadone maintenance treatment at least as  effectively as  specia l is t cl inics .
K  Case management l inks  detox to treatment (2006). Si ting case managers  at detoxi fication services  transformed them in to gateways  to longer term treatment,
part of a  broader 'recovery revolution' in Phi ladelphia.
K  No long-term benefi t from inpatient v. outpatient detoxi fication (2011). Randomly a l locating methadone-maintained patients  in Birmingham (UK) to an inpatient
(v. outpatient) environment for their lofexidine-based detoxi fication did not improve the low abstinence rate after discharge.
K  Specia l is t and inpatient opiate detoxi fication improve completion rates  (2000). Cost-effectiveness  and cost-benefi t analys is  based on two UK studies , one of
which showed that far more patients  who choose or are randomly a l located to an inpatient setting complete detoxi fication, the other that the most effective
inpatient setting is  a  specia l is t drug addiction ward rather than a general  psychiatry ward.
K  High qual i ty primary care helps  control  substance use after detoxi fication (2007). The substance use of US patients  referred to primary care after detoxi fication
was found to be related to a  recognised measure of the general  qual i ty of primary care.
R  Pharmacotherapies  for opioid dependence (2009). Book by leading Austral ian authors  includes  evidence on how best to organise and orient
pharmacotherapies .
R  Implementation strategies  ([Austral ian] National  Centre for Education and Training on Addiction, 2008). Lessons  from health promotion and medical  care on
how to improve addiction treatment practice including organisational  and administrative strategies .
G  Making recovery the paradigm for medication-based treatment ([UK] National  Treatment Agency for Substance Misuse, 2012). Cl inical  consensus  developed for
UK government on how medication-based treatment for heroin addiction can be made more recovery-oriented, focus ing on methadone maintenance and al l ied
programmes.
MORE  This  search retrieves  a l l  relevant analyses .
For subtopics  go to the subject search page and hot topic on why some treatment services  are more effective than others .
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What is this cell about? About the treatment of drug dependence in a medical context and/or involving medical care. Medications are
the main distinguishing feature, but treatment also entails potentially therapeutic interactions with clinical and other staff. All this
normally takes place in the context of a treatment organisation. As well as concrete things like staff, management committees,
resources, and an institutional structure, organisations have links with other organisations, histories, values, priorities, and an ethos,
determining whether they offer an environment in which staff and patients/clients can maximise their potential. For these and other
reasons, agencies also differ in how keenly and effectively they seek and incorporate evidence-based practices. At this distance from the
preoccupation with intervention effectiveness, research is scarce, and generic sources beyond the scope of the matrices become more
important. Despite the slim pickings for medical services in particular, we can fall back on the studies and reviews which deal with
similar issues across drug treatment, to be found in cell D2.
Where should I start? We suggest this UK guidance on how methadone clinics and other medication-based treatment services can be
(re)oriented to long-term recovery. Turn to the Findings analysis and click the title to download the report. Then turn to the table on 9 on
how to recognise whether your service is recovery-orientated and on what it would take to fill in any gaps. This single page makes real
the guidance’s vision of treatment as a dynamic, goal-orientated movement, ideally towards sustainably drug-free treatment exit – the
opposite of the ‘parking’ accusation levelled at current services. If implemented, the table’s recommendations would replace ad hoc
service provision which may not identify opportunities for progress or be able to take them when they happen, with a service clear about
its vision, which systematically monitors progress towards it, gears staff and programme up to promote it, and reaches out to other
resources which can also help.
Note though, the vision here is rather different from the maintenance/harm reduction vision which animated the Toronto clinic in the
Highlighted study below, and to the commitment to indefinite/long-term maintenance which characterised the most effective clinics in US
and Australian seminal studies. Whatever it is, a third seminal study highlights the importance of having some kind of “rationale” for
treatment, some vision of what it is there for to knit the strands in to a coherent, goal-oriented programme.
Highlighted study This object lesson from a methadone clinic in Toronto in Canada shows that a limited pot of money can be stretched
to double the caseload by loosening up the programme and making it more flexibly patient-centred – extremely relevant in these
resource-constrained times. The changes took place in 1995 and 1996 at a clinic run by Ontario’s highly respected clinical and research
centre. Original articles do not seem to be freely available, but the Findings analysis gives the essentials, and these are supplemented
below.
In sum, at first the clinic’s intake was capped to 100 patients and a long waiting list developed but was rarely whittled down. Only high-
risk patients could be accommodated. The philosophy was described as “abstinence-based”. From the description of how it changed, we
can assume it: expected patients to rapidly cease illegal drug use; discharged them when frequent urine tests showed they hadn’t;
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enforced long-term supervised consumption at the clinic; set doses with little reference to the patient, in a largely arbitrary manner and
capped them at 100mg/day; and required attendance at counselling sessions, whether needed or desired or not.
After extensive consultations including with patient advocates, during 1995 and 1996 a patient-centred regimen was introduced.
Loosening the reins, it let patients decide whether they wanted counselling, gave them a greater say over doses which were no longer
capped, cut down on urine tests, allowed more take-home doses, treated continued illegal drug use as a sign more treatment was
needed, not that it should end, and accepted goals short of abstinence from illegal drugs. More front-line doctors and therapists were
employed, funded largely by budgetary and ‘back-office’ efficiencies.
Check our analysis and you will see that patient numbers more than doubled, the waiting list was eliminated, the case-mix diversified to
include users of opioids other than heroin, and average doses rose from sub-optimal (below 60mg/day) to over 90mg/day and the range
widened, a sign of greater individualisation. Even when like-for-like patients were compared, allowing them to set their own pace in
reducing illegal drug use did not mean more used ‘on top’; within six months of starting treatment half the patients were no longer using
illegal opioids. Patients also attended as many therapy sessions as when these were mandatory, doctors were seen more often, and
generally there were no signs that widening access and relaxing the regimen had attracted patients more interested in getting drugs than
in treatment. Confrontations over continued illegal drug use could give way to potentially more productive interactions. Readers of the
bite before this one will not be surprised that greater user involvement in dosing and relaxing counselling and supervised consumption
requirements did not affect outcomes.
Issues to think about
 Ethos, dose, organisation: are these the three pillars of a pharmacological intervention? This Australian study paints a vivid picture
of the ‘characters’ of three methadone clinics – their ethos and working environments – and relates these to their impacts on 304
patients, aided by repeated interviews over a 12-month period. The three characters seem common and important prototypes, probably
familiar to many who have visited or worked in such clinics. The by-line of the original study included several internationally respected
Australian researchers, of whom one (James Bell) gave an account of the study in what was and arguably still is the most informative
book ever on methadone maintenance and allied therapies. It supplemented the original research report with practice lessons from the
findings. This account is reproduced in the Findings entry, which also links to the freely available original research report.
James Bell deduced three success factors from his work, but implicitly there is another and a higher order factor – a service should have
some guiding vision, whatever that might be. In all three clinics, treatment “was something of a ritual, with little clear rationale for what
was occurring. The absence of a frame of reference for approaching methadone treatment was apparent, not just in the differences
between the clinics, but in the interaction between staff and patients.”
Of the three success factors, most fundamental is a “treatment” ethos. If that seems obvious, look at the description of the working style
of clinic 1: “businesslike ... with little attention to ‘treatment’.” For the author, a treatment ethos is a “framework in which all interactions
with patients are understood as part of the care of the individual. Thus issues of anger, conflict and acting out become part of the
material being worked with, rather than an irritation or obstacle to the smooth running of the clinic.”
This ethos in turn affects dosing strategies and levels – the second success factor – demanding an individualised approach. In another of
the author’s studies, it was partly through its impact on dosing that ethos seemed to affect heroin use, leading to more use when an
abstinence orientation meant doses were restrained. That may also have been one of the mechanisms in action at the methadone clinic
in Toronto featured above as the Highlighted study. Finally, the organisation of the clinic also seems important. For the sake of both
patients and staff, treatment should be “Structured and well-organised ... with clear rationale and objectives.” Absence of good
organisation meant clinic 3 “was chaotic” and despite usual dose levels, the dissatisfied patients had poor outcomes.
James Bell also contributed the evidence review behind the UK guidance featured under Where should I start? Look at the review and you
will see that nearly two decades later, these factors remained supported by the evidence and relevant to a recovery focus. Ethos, dose,
organisation: do these for you remain essential elements of an effective medication-based service, particularly of methadone
maintenance, and are they sufficient in themselves?
Thanks for their comments on this entry in draft to James Bell of the National Addiction Centre in London, England. Commentators bear no responsibility for the text
including the interpretations and any remaining errors.
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